Desitin Arzneimittel GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Piribedil, ATC N04BC08 for the period 01072024 - 30062025 (one-year extension option)

Posted On: 2026-07-06

Germany, July 6 -- Germany based Desitin Arzneimittel GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Piribedil, ATC N04BC08 for the period 01072024 - 30062025 (one-year extension option) . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Desitin Arzneimittel GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Piribedil, ATC N04BC08 for the period 01072024 - 30062025 (one-year extension option)